<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>识林 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-04T23:25:11+08:00</updated>
  <subtitle>服务于制药行业企业、机构及人员的知识与管理平台</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>瑞德西韦带来的优先审评券：烫手山芋？</title>
    <updated>2020-11-04T06:51:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/ntlxFGY5xcUAmGdsxWYDkA</id>
    <link href="https://mp.weixin.qq.com/s/ntlxFGY5xcUAmGdsxWYDkA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>FDA 紧急使用授权程序正逐步改善，应更加透明</title>
    <updated>2020-11-04T06:51:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/mTTB_e9aMpDFkTATDSC3dg</id>
    <link href="https://mp.weixin.qq.com/s/mTTB_e9aMpDFkTATDSC3dg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>从新冠候选疫苗 BNT162b 看 mRNA 疫苗</title>
    <updated>2020-11-03T07:00:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-03:/s/zbsKKyA4m8dRGieD0e34Pw</id>
    <link href="https://mp.weixin.qq.com/s/zbsKKyA4m8dRGieD0e34Pw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>一个影响重大的仿制药诉讼案例：标签剔除可能构成专利侵权</title>
    <updated>2020-11-03T07:00:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-03:/s/XnRquw_sQSk0fQ58HB38-A</id>
    <link href="https://mp.weixin.qq.com/s/XnRquw_sQSk0fQ58HB38-A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>一周回顾：药品审评审批信息公开，FDA仿制药申报中的参照药品，限制进口的基本药物清单，礼来抗体工厂两封483，欧盟亚硝胺实施计划</title>
    <updated>2020-11-02T06:28:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-02:/s/enWlHqFgasexlnnHS769Iw</id>
    <link href="https://mp.weixin.qq.com/s/enWlHqFgasexlnnHS769Iw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>英国 MHRA 发布使用真实世界证据的随机对照试验指南</title>
    <updated>2020-11-02T06:28:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-02:/s/t-haDuSQvhwJ3pgB-cw1uw</id>
    <link href="https://mp.weixin.qq.com/s/t-haDuSQvhwJ3pgB-cw1uw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【质量对话】救火与防火</title>
    <updated>2020-11-01T06:32:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-01:/s/INAzQUUy2WNGldbwN5Bb9w</id>
    <link href="https://mp.weixin.qq.com/s/INAzQUUy2WNGldbwN5Bb9w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>FDA 发布需从美国工厂采购的基本药物和关键物料清单</title>
    <updated>2020-10-31T06:42:34+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-31:/s/-QfwS8vzWKHVxAXKnIJs3g</id>
    <link href="https://mp.weixin.qq.com/s/-QfwS8vzWKHVxAXKnIJs3g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>EMA 推出亚硝胺杂质短中长期完整实施计划</title>
    <updated>2020-10-30T06:42:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-30:/s/LGwpVPImipPjYo_phLLtAQ</id>
    <link href="https://mp.weixin.qq.com/s/LGwpVPImipPjYo_phLLtAQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>FDA 研究揭示可用来预测仿制药申报可能性的因素</title>
    <updated>2020-10-30T06:42:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-30:/s/L0EQYlCbyjvq5A5zvtVf8g</id>
    <link href="https://mp.weixin.qq.com/s/L0EQYlCbyjvq5A5zvtVf8g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>FDA 仿制药申报中使用的参照药品重要指南定稿</title>
    <updated>2020-10-29T06:40:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-29:/s/7w2ilEU5hOWBOx7kKUBmhA</id>
    <link href="https://mp.weixin.qq.com/s/7w2ilEU5hOWBOx7kKUBmhA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>EMA 新负责人：用得到且买得起的药才是有价值的药</title>
    <updated>2020-10-29T06:40:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-29:/s/LjRawW80u39UugmVKjlL9w</id>
    <link href="https://mp.weixin.qq.com/s/LjRawW80u39UugmVKjlL9w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>基因治疗药 Zolgensma 日本上市审批之路揭示的经验教训</title>
    <updated>2020-10-28T05:58:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-28:/s/fJLp8_-OlyzSMumknxxvUA</id>
    <link href="https://mp.weixin.qq.com/s/fJLp8_-OlyzSMumknxxvUA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【招聘】识林求贤</title>
    <updated>2020-10-28T05:58:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-28:/s/MmW7bsNkFvzG_6JAh67U-A</id>
    <link href="https://mp.weixin.qq.com/s/MmW7bsNkFvzG_6JAh67U-A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>欧盟发布老年人药品开发考虑因素，鼓励以患者为中心的方法</title>
    <updated>2020-10-27T06:31:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-27:/s/mRYQki6RRaPrM-pSGkC2cg</id>
    <link href="https://mp.weixin.qq.com/s/mRYQki6RRaPrM-pSGkC2cg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>尹放东：产品与质量和工艺与控制的科学定义与实际应用</title>
    <updated>2020-10-27T06:31:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-27:/s/e_ddxmc2RXYdYQBNj2fGHQ</id>
    <link href="https://mp.weixin.qq.com/s/e_ddxmc2RXYdYQBNj2fGHQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>一周回顾：药审中心对某些注射剂一致性评价补充资料将不予批准，FDA批准首个新冠治疗药，欧盟和WHO发布利福平中亚硝胺杂质的通告</title>
    <updated>2020-10-26T06:35:41+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-26:/s/hbXcGon8biPOqjmmythyCg</id>
    <link href="https://mp.weixin.qq.com/s/hbXcGon8biPOqjmmythyCg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>美国生物类似药市场最新预测，未来五年内将节约一千亿美元</title>
    <updated>2020-10-26T06:35:41+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-26:/s/viJjSNNB-7Vu4qHmoycFjw</id>
    <link href="https://mp.weixin.qq.com/s/viJjSNNB-7Vu4qHmoycFjw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>